A New Zealand case study: The use of ozone therapy as an adjunctive support treatment with radiation therapy in prostate cancer. Case report.

Resumen

Ozone therapy has been shown to be an effective adjunctive therapy with radiation therapy (RT). The aim of this case report is to discuss the benefits of using ozone therapy (OT) as a complementary tool in a patient with prostate cancer who was referred to have RT therapy after a nodal oligo-recurrenceoligo-recurrence of prostate adenocarcinoma cancer was detected after having  robotic prostatectomy April 2021.

The patient initially faced twenty-three sessions of radiation therapy (RT) over 5 weeks and chose to also use Goserelin, a novel anti-androgen, with Zytiga (abiraterone) and prednisone. He was concerned about the side effects of RT, short-term and long-side effects such as fatigue, burns, and incontinence.

There is an increase in patients reaching out for different forms of  treatment modalities and there is a greater need for physicians to understand about these options. However,  the terms associated with adjunctive and alternative therapy has meant confusion and limitations.    The use of the umbrella term ‘CAM’ (complementary and alternative therapies) is discussed and how this is used within New Zealand’s legal and medical system with the view it  could be more clearly defined, which may result better  doctor-patient communication.

We have concluded the use of OT (ozonated saline IV [03SS]), together with minor autohemotherapy [MiAH]) as the primary adjunctive therapy,  in  this case study proved to be both safe and effective when used in combination with conventional treatment.   Fifteen months after RT treatment, the patient is healthy with no side-effects from RT, but the patient had experienced side-effects  from the drug therapy  which was part of the conventional treatment plan. At the time of this report,  the drug therapy still has another six months to conclude